78 related articles for article (PubMed ID: 18800350)
1. K-ras cancer gene mutations in lung tumors from female Swiss (CD-1) mice exposed transplacentally to 3'-azido-3'-deoxythymidine.
Koujitani T; Ton TV; Lahousse SA; Hong HH; Wakamatsu N; Sills RC
Environ Mol Mutagen; 2008 Dec; 49(9):720-6. PubMed ID: 18800350
[TBL] [Abstract][Full Text] [Related]
2. Genetic alterations in K-ras and p53 cancer genes in lung neoplasms from Swiss (CD-1) male mice exposed transplacentally to AZT.
Hong HH; Dunnick J; Herbert R; Devereux TR; Kim Y; Sills RC
Environ Mol Mutagen; 2007; 48(3-4):299-306. PubMed ID: 16395694
[TBL] [Abstract][Full Text] [Related]
3. Skin tumorigenesis and Ki-ras and Ha-ras mutations in tumors from adult mice exposed in utero to 3'-azido-2',3'-dideoxythymidine.
Zhang Z; Diwan BA; Anderson LM; Logsdon D; Olivero OA; Haines DC; Rice JM; Yuspa SH; Poirier MC
Mol Carcinog; 1998 Sep; 23(1):45-51. PubMed ID: 9766437
[TBL] [Abstract][Full Text] [Related]
4. High frequency of ras mutations in forestomach and lung tumors of B6C3F1 mice exposed to 1-amino-2,4-dibromoanthraquinone for 2 years.
Hayashi S; Hong HH; Toyoda K; Ton TV; Devereux TR; Maronpot RR; Huff J; Sills RC
Toxicol Pathol; 2001; 29(4):422-9. PubMed ID: 11560247
[TBL] [Abstract][Full Text] [Related]
5. Increased frequency of K-ras mutations in lung neoplasms from female B6C3F1 mice exposed to ozone for 24 or 30 months.
Sills RC; Hong HL; Greenwell A; Herbert RA; Boorman GA; Devereux TR
Carcinogenesis; 1995 Jul; 16(7):1623-8. PubMed ID: 7614698
[TBL] [Abstract][Full Text] [Related]
6. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
[TBL] [Abstract][Full Text] [Related]
7. Toxicology and carcinogenesis studies of transplacental AZT (Cas No. 30516-87-1) in Swiss (CD-1®) mice (in utero studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jun; (522):1-184. PubMed ID: 17160102
[TBL] [Abstract][Full Text] [Related]
8. Toxicology and carcinogenesis studies of mixtures of 3'-azido-3'-deoxythymidine (AZT), lamivudine (3TC), nevirapine (NVP), and nelfinavir mesylate (NFV) (Cas Nos. 30516-87-1, 134678-17-4, 129618-40-2, 159989-65-8) in B6C3F1 Mice (transplacental exposure studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2013 Jan; (569):1-212. PubMed ID: 23385634
[TBL] [Abstract][Full Text] [Related]
9. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
Goodrow T; Reynolds S; Maronpot R; Anderson M
Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
[TBL] [Abstract][Full Text] [Related]
10. Mouse lung tumors exhibit specific Ki-ras mutations following transplacental exposure to 3-methylcholanthrene.
Wessner LL; Fan M; Schaeffer DO; McEntee MF; Miller MS
Carcinogenesis; 1996 Jul; 17(7):1519-26. PubMed ID: 8706258
[TBL] [Abstract][Full Text] [Related]
11. Polymerase chain reaction/sequencing analysis of ras mutations in paraffin-embedded tissues as compared with 3T3 transfection and polymerase chain reaction/sequencing of frozen tumor deoxyribonucleic acids.
Goodrow TL; Prahalada SR; Storer RD; Manam SV; Leander KR; Kraynak AR; van Zwieten MJ; Nichols WW; Bradley MO
Lab Invest; 1992 Apr; 66(4):504-11. PubMed ID: 1583889
[TBL] [Abstract][Full Text] [Related]
12. [Screening for K-ras mutations in colorectal and lung cancers by using a novel real-time PCR with ADx-K-ras kit and Sanger DNA sequencing].
Zhang HP; Fu L; Chen PQ; Ye YB; Ji TH; Zheng LM
Zhonghua Bing Li Xue Za Zhi; 2010 Nov; 39(11):757-61. PubMed ID: 21215167
[TBL] [Abstract][Full Text] [Related]
13. Ki-ras mutations are an early event and correlate with tumor stage in transplacentally-induced murine lung tumors.
Leone-Kabler S; Wessner LL; McEntee MF; D'Agostino RB; Miller MS
Carcinogenesis; 1997 Jun; 18(6):1163-8. PubMed ID: 9214598
[TBL] [Abstract][Full Text] [Related]
14. K-ras mutations in lung tumors from p53 mutant mice exposed to cigarette smoke.
Yao R; Wang Y; D'Agostini F; Izzotti A; Lubet RA; You M; De Flora S
Exp Lung Res; 2005 Mar; 31(2):271-81. PubMed ID: 15824025
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations in K-ras and p53 cancer genes in lung neoplasms from B6C3F1 mice exposed to cumene.
Hong HH; Ton TV; Kim Y; Wakamatsu N; Clayton NP; Chan PC; Sills RC; Lahousse SA
Toxicol Pathol; 2008 Jul; 36(5):720-6. PubMed ID: 18648094
[TBL] [Abstract][Full Text] [Related]
16. Gene expression studies demonstrate that the K-ras/Erk MAP kinase signal transduction pathway and other novel pathways contribute to the pathogenesis of cumene-induced lung tumors.
Wakamatsu N; Collins JB; Parker JS; Tessema M; Clayton NP; Ton TV; Hong HH; Belinsky S; Devereux TR; Sills RC; Lahousse SA
Toxicol Pathol; 2008 Jul; 36(5):743-52. PubMed ID: 18648096
[TBL] [Abstract][Full Text] [Related]
17. High frequency of codon 61 K-ras A-->T transversions in lung and Harderian gland neoplasms of B6C3F1 mice exposed to chloroprene (2-chloro-1,3-butadiene) for 2 years, and comparisons with the structurally related chemicals isoprene and 1,3-butadiene.
Sills RC; Hong HL; Melnick RL; Boorman GA; Devereux TR
Carcinogenesis; 1999 Apr; 20(4):657-62. PubMed ID: 10223196
[TBL] [Abstract][Full Text] [Related]
18. Detection of K-ras mutations in lung carcinomas: relationship to prognosis.
Keohavong P; DeMichele MA; Melacrinos AC; Landreneau RJ; Weyant RJ; Siegfried JM
Clin Cancer Res; 1996 Feb; 2(2):411-8. PubMed ID: 9816185
[TBL] [Abstract][Full Text] [Related]
19. [Mutations in the 61st codon of the c-Ki-ras oncogene during transplacental lung tumor induction in mice and their difference in spontaneous and induced tumors].
Loktionov AS
Mol Biol (Mosk); 1991; 25(6):1517-25. PubMed ID: 1813798
[TBL] [Abstract][Full Text] [Related]
20. Multiorgan transplacental and neonatal carcinogenicity of 3'-azido-3'-deoxythymidine in mice.
Diwan BA; Riggs CW; Logsdon D; Haines DC; Olivero OA; Rice JM; Yuspa SH; Poirier MC; Anderson LM
Toxicol Appl Pharmacol; 1999 Nov; 161(1):82-99. PubMed ID: 10558926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
